Efficacy and Safety in Key Patient Subgroups of Nivolumab (Nivo) Alone Or Combined with Ipilimumab (Ipi) Versus Ipi Alone in Treatment-Naive Patients with Advanced Melanoma
Authors
Larkin, JChiarion-Sileni, V
Gonzalez, R
Grob, J
Cowey, C
Lao, C
Wagstaff, J
Hogg, D
Hill, A
Carlino, M
Wolter, P
Lebbe, C
Schachter, J
Thomas, L
Hassal, J
Lorigan, Paul C
Walker, D
Jiang, J
Hodi, F
Wolchok, J
Issue Date
2015